A hetero-bimetallic Ru(II)-Ir(III) photosensitizer for effective cancer photodynamic therapy under hypoxia

Chem Commun (Camb). 2024 Mar 5;60(20):2776-2779. doi: 10.1039/d4cc00072b.

Abstract

A hetero-bimetallic Ru(II)-Ir(III) photosensitizer was developed. Upon light exposure, contrary to the homogeneous Ru(II)-Ru(II) and Ir(III)-Ir(III) complexes that can only produce singlet oxygen, Ru(II)-Ir(III) can generate multiple reactive oxygen species and kill hypoxic tumors. This study presents the first example of a hetero-bimetallic type-I and type-II dual photosensitizer.

MeSH terms

  • Humans
  • Hypoxia
  • Neoplasms* / drug therapy
  • Photochemotherapy*
  • Photosensitizing Agents / pharmacology
  • Ruthenium* / pharmacology
  • Singlet Oxygen

Substances

  • Photosensitizing Agents
  • Singlet Oxygen
  • Ruthenium